CORONARY and the kidney substudy were supported by grants from the Canadian Institutes of Health Research.
Dr. Garg reported receiving grant funding from Astellas, Roche, and Pfizer. Another author (Dr. P.J. Devereaux) reported receiving grants from Abbott Diagnostics, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Covidien, Roche Diagnostics, and Stryker, and one (Dr. Chirag R. Parikh) reported participating on a data monitoring committee for a phase II trial sponsored by AbbVie. The remaining authors reported having no disclosures.